Aramine,
Araminol,
Bitartrate, Metaraminol,
hydroxyphenylpropanolamine,
Isophenylephrine,
m Hydroxynorephedrine,
m Hydroxyphenylpropanolamine,
m-Hydroxynorephedrine,
m-hydroxyphenylpropanolamine,
meta Hydroxynorephedrine,
meta-Hydroxynorephedrine,
Metaradrin,
Metaraminol,
Metaraminol Bitartrate,
Metaraminol Bitartrate (1:1),
Metaraminol Tartrate,
Tartrate, Metaraminol,
Metaraminol bitartrate,
33402-03-8,
Metaraminol (tartrate),
(-)-Metaraminol bitartrate,
Araminum,
Metaradrine tartrate,
UNII-ZC4202M9P3,
Metaraminol (+)-bitartrate salt,
Levicor,
Metaramin,
Levicor ampullen,
Araminum ampullen,
ZC4202M9P3,
Pressonex bitartrate,
Metaraminol Tartrate,
l-Metraminol bitartrate,
Aramine (sympathominetic),
Metaraminol tartrate (1:1),
IMS metaraminol bitartrat ampullen,
Metaraminol (R,R)-hydrogentartrat,
Metaraminol hydrogen (+)-tartrate,
EINECS 251-502-3,
1-alpha-(1-Aminoethyl)-m-hydroxybenzyl alcohol bitartrate,
(-)-alpha-(1-Aminoethyl)-m-hydroxybenzyl alcohol bitartrate,
l-1-(m-Hydroxyphenyl)-2-amino-1-propanol-d-hydrogen tartrate,
1-alpha-(1-Aminoethyl)-m-hydroxybenzyl alcohol hydrogen d-tartrate,
C9H13NO2.C4H6O6,
(-)-alpha-(1-Aminoethyl)-m-hydroxybenzyl alcohol tartrate (1:1) (salt),
3-[(1R,2S)-2-amino-1-hydroxypropyl]phenol;(2R,3R)-2,3-dihydroxybutanedioic acid,
Benzyl alcohol, alpha-(1-aminoethyl)-m-hydroxy-, (-)-, tartrate (1:1) (salt),
Metaraminol bitartrate [USP:JAN],
Benzenemethanol, alpha-(1-aminoethyl)-3-hydroxy-, (R-(R*,S*))-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1) (salt),
Metaraminol bitartrate (hydrogen l-tartrate),
Prestwick3_000197,
Metaraminol bitartrate salt,
AC1L9B4D,
SCHEMBL40982,
BSPBio_000153,
BSPBio_003506,
BPBio1_000169,
BENZYL ALCOHOL, alpha-(1-AMINOETHYL)-m-HYDROXY-, TARTRATE (1:1), D-(-)-,
HMS2093A03,
Metaraminol bitartrate (JAN/USP),
Pharmakon1600-01503251,
Benzenemethanol, alpha-((1S)-1-aminoethyl)-3-hydroxy-, (alphaR)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1),
EX-A1348,
HY-B1116,
2539AH,
MFCD00238763,
NSC758425,
API0003261,
CCG-213141,
CS-4715,
NSC-758425,
D01019,
402M038,
SR-05000001611,
J-019180,
SR-05000001611-1,
Metaraminol bitartrate, United States Pharmacopeia (USP) Reference Standard,
(1R,2S)-2-amino-1-(3-hydroxyphenyl)propan-1-ol hydrogen (2R,3R)-tartrate,
3-((1R,2S)-2-amino-1-hydroxypropyl)phenol (2R,3R)-2,3-dihydroxysuccinate,
3-[(1R,2S)-2-amino-1-hydroxypropyl]phenol; (2R,3R)-2,3-dihydroxybutanedioic acid,
17171-57-2,
Benzenemethanol, a-[(1S)-1-aminoethyl]-3-hydroxy-, (aR)-,(2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt),
Pressorol,
Aramine,
Aramine (TN),
C13H19NO8,
Metaraminol bitartrate [USAN:JAN],
CID441414,
ACN-043401,
C9-H13-N-O2.C4-H6-O6,
(-)-m-Hydroxyphenylpropanolamine bitartrate salt,
Benzyl alcohol, .alpha.-(1-aminoethyl)-m-hydroxy-, (-)-, tartrate (1:1) (salt),
54-49-9,
Bencenometanol, alfa-[(1S)-1-aminoetil]-3-hidroxi-, (alfa R)-, (2R, 3R)-2,3-dihidroxibutanedioato (1:1),
Benzenemethanol, .alpha.-(1-aminoethyl)-3-hydroxy-, [R-(R*,S*)]-, [R-(R*,R*)]-2,3-dihydroxybutanedioate (1:1) (salt),